126 related articles for article (PubMed ID: 22747472)
1. Pentraxin-3 expression in acute renal allograft rejection.
Imai N; Nishi S; Yoshita K; Ito Y; Osawa Y; Takahashi K; Nakagawa Y; Saito K; Takahashi K; Narita I
Clin Transplant; 2012 Jul; 26 Suppl 24():25-31. PubMed ID: 22747472
[TBL] [Abstract][Full Text] [Related]
2. SDF-1 expression is elevated in chronic human renal allograft rejection.
Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK
Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 2 receptor expression in renal biopsies and the diagnosis of acute allograft rejection.
Mathan A; Kuruvilla S; Abraham G
Indian J Pathol Microbiol; 2006 Jan; 49(1):12-6. PubMed ID: 16625964
[TBL] [Abstract][Full Text] [Related]
4. Local expression of C-reactive protein is associated with deteriorating graft function in acute and chronic failure of kidney transplants.
Jabs WJ; Meier M; Lamprecht P; Steinhoff J; Nitschke M
Nephron Clin Pract; 2011; 117(4):c390-7. PubMed ID: 21071964
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
[TBL] [Abstract][Full Text] [Related]
7. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
[TBL] [Abstract][Full Text] [Related]
8. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
Carstens J; Ozbay A; Tørring C; Hansen HE
Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
[TBL] [Abstract][Full Text] [Related]
9. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
[TBL] [Abstract][Full Text] [Related]
10. CD256 can be found in antibody-mediated renal allograft rejection tissues.
Xu H; He X; Zhao W; Guo H; Shi Q; Zhu Y; Zhang X
Clin Lab; 2012; 58(5-6):411-8. PubMed ID: 22783569
[TBL] [Abstract][Full Text] [Related]
11. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
Brügger-Andersen T; Pönitz V; Kontny F; Staines H; Grundt H; Sagara M; Nilsen DW
Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
Nur E; van Beers EJ; Martina S; Cuccovillo I; Otten HM; Schnog JJ; Meijers JC; Mantovani A; Brandjes DP; Bottazzi B; Biemond BJ;
Blood Cells Mol Dis; 2011 Mar; 46(3):189-94. PubMed ID: 21256776
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant nuclear renal scans correlate with renal injury biomarkers and early allograft outcomes.
Obeidat MA; Luyckx VA; Grebe SO; Jhangri GS; Maguire C; Zavodni A; Jackson S; Mueller TF
Nephrol Dial Transplant; 2011 Sep; 26(9):3038-45. PubMed ID: 21321005
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
[TBL] [Abstract][Full Text] [Related]
17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
18. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
20. Impact of chemokine receptor CX3CR1 in human renal allograft rejection.
Hoffmann U; Bergler T; Segerer S; Rümmele P; Krüger B; Banas MC; Reinhold S; Banas B; Krämer BK
Transpl Immunol; 2010 Aug; 23(4):204-8. PubMed ID: 20600902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
